🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — pooled safety analysis Page 2

Pancreatitis risk assessment — pooled safety analysis

Dr.MetabolicMD Sun, Jun 7, 2026 at 2:11 AM 15 replies 291 viewsPage 2 of 3
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 7, 2026 at 2:34 AM#6

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

11 6DadBodDave, AmyNC_wife, SkepticalSean and 8 others
Reply Quote Save Share Report
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Jun 7, 2026 at 2:43 AM#7

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

Last edited: Jun 7, 2026 at 6:43 AM
10 5NicoleRaleigh, james_edin, FranDenver and 7 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Jun 7, 2026 at 2:53 AM#8
dan_philly said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

9 4MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Jun 7, 2026 at 3:02 AM#9

OP back with an update, since a thread like this is useless without one.

Reporting back with a partial result, because a partial result is still better than silence. Two of the three things suggested helped; I cannot separate them and I am not going to pretend otherwise.

Last edited: Jun 7, 2026 at 5:02 AM
8 3Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 5 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Jun 7, 2026 at 3:46 AM#10
VendorMark said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

8 6mike.trainer_LA, sarah_nash92, FitDadDave and 5 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Fatigue on semaglutide — caloric deficit vs direct drug effect25 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register